Lupus

Lupus hope found in psoriasis and cancer drugs

Viral and fungal infections take over as key opportunistic diseases

EULAR highlights

CAR T-cell therapy shows promise in lupus

Tripling paeds rheum positions among inquiry recommendations

ANA and RF in direct-to-consumer free-for-all

A silver lining to sulfasalazine’s covid fear

Beyond ‘brain fog’ – cognitive dysfunction in lupus patients
